This issue we welcome a new face to the Lung Foundation – Jane Kerr – who will be known to many of our members through her previous roles in both the pharmaceutical industry and clinical work.
Please tell us a little about yourself and how you came to be involved with the Lung Foundation
My background is as a respiratory clinical nurse consultant who moved into the pharma industry in the therapeutic area of oncology, mostly specifically in the lung cancer arena. My involvement with the Lung Foundation came about well over 10 years ago through sponsorships from the various companies I worked for and mostly through membership of the LCCG.
What is your role within the Lung Foundation and what are your priorities?
My role with the Lung Foundation is as the General Manger: Thoracic Cancers and Rare Lung Disease. My priority is to have patients, carers and survivors front and centre of all that we do.
What are you most looking forward to in working at the Lung Foundation?
Working with a dedicated group of people in therapeutic areas I’ve always been passionate about.